Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
PA9159 is a highly potent novel corticosteroid. The purpose of this study is to evaluate the
safety, efficacy and characteristics of population pharmacokinetics of multiple dosing of
PA9159 Nasal Spray in patients with seasonal allergic rhinitis.